Pro Share Advisors LLC Bluebird Bio, Inc. Transaction History
Pro Share Advisors LLC
- $36.7 Billion
- Q1 2024
A detailed history of Pro Share Advisors LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 47,745 shares of BLUE stock, worth $54,429. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,745
Previous 24,699
93.31%
Holding current value
$54,429
Previous $34,000
79.41%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding BLUE
# of Institutions
171Shares Held
104MCall Options Held
814KPut Options Held
1.23M-
Black Rock Inc. New York, NY15.2MShares$17.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$12 Million0.0% of portfolio
-
Granahan Investment Management, LLC Waltham, MA7.71MShares$8.79 Million0.35% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.39MShares$7.29 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.24MShares$7.11 Million0.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $87.9M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...